Financial News

Financial Report: Akorn

Revenues down 32% in the second quarter

By: Contract Pharma

Contract Pharma Staff

Akorn 2Q Revenues: $120 million (-32%) 2Q Loss: $69 million (loss of $112 million 2Q19) YTD Revenues: $325 million (-6%) YTD Loss: $325.4 million (loss of $193.8 million 2Q19) Comments: Decrease in revenue in the quarter resulted from a $54.9 million decline in organic revenue, and a $5.6 million decline in revenue from discontinued products, partially offset by a $2.8 million increase in net revenue from new products. Goodwill impairments during the six month period ended Ju...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters